NASDAQ$TNGX
Tango Therapeutics Inc · Q3 2025 earnings
Q3 2025 earnings · · Before market open · Investor relations
Briefing
TNGX Q3 2025 — $53.8M revenue
Further, we face substantial competition, which may result in others discovering, developing or commercializing products before or more successfully than we d. Tango Therapeutics Inc reported Q3 2025 results. Net income of $62.8M. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $53.8M.
- Net income: $62.8M.
- Operating income: $69K.
Headline financials
Revenue & EPS history
Tango Therapeutics · Revenue · Quarterly
$53.8M
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2025
+0.6%
Avg return
Earnings day
+6.7%
Avg return
5 days after
+25.5%
Avg return
30 days after
58%
11 / 19 earnings
Positive
+36.4%
Q4 2025
Best reaction
-45.4%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +8.6% | -12.1% | — | |
| Q4 2025 | +36.4% | +33.6% | +75.1% | |
| Q3 2025 | +0.2% | -1.7% | +23.6% | |
| Q1 2025 | +17.1% | +31.6% | +315.8% | |
| Q4 2024 | -6.5% | -21.0% | -36.9% | |
| Q3 2024 | -45.4% | -34.7% | -34.7% | |
| Q2 2024 | -1.8% | -5.7% | +20.9% | |
| Q1 2024 | -0.8% | -6.9% | -12.1% | |
| Q4 2023 | -9.7% | -14.4% | -17.4% | |
| Q3 2023 | +3.8% | -12.1% | +6.6% | |
| Q2 2023 | +1.2% | +120.9% | +113.5% | |
| Q1 2023 | +6.4% | +4.4% | -0.3% | |
| Q4 2022 | -9.4% | -5.3% | -21.6% | |
| Q3 2022 | -5.3% | +6.7% | -1.3% | |
| Q2 2022 | +22.4% | +32.8% | -8.1% | |
| Q1 2022 | -7.6% | +1.2% | -3.8% | |
| Q4 2021 | +0.3% | +6.8% | +1.3% | |
| Q3 2021 | +0.4% | +5.2% | -10.7% | |
| Q2 2021 | +1.1% | -2.2% | +49.4% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro